Axa
COLL icon

Axa’s Collegium Pharmaceutical COLL Stock Holding History

Axa’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,913
Closed -$255K – 1067
2024
Q4 		$255K Sell
8,913
-3,282
-27% -$109K ﹤0.01% 1009
2024
Q3 		$471K Buy
12,195
+5,694
+88% +$203K ﹤0.01% 971
2024
Q2 		$209K Buy
+6,501
New +$225K ﹤0.01% 1022

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa's COLL Position: Q1 2025 in Review

Axa sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 8,913 shares — an estimated $255K sold.

Axa first reported a position in COLL in Q2 2024 and held it in 3 quarters. The position peaked at $471K in Q3 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Axa reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Axa sold 8,913 Collegium Pharmaceutical shares in Q1 2025, an estimated $255K.
  • Axa first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 3 quarters.
  • Axa's Collegium Pharmaceutical position peaked at $471K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.